Physician profile
Holly Gilmer
NPI 1881638930
$1,922.49
in general payments reported to CMS, 2019-2025
21 companies · $600 in 2025
The $600 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $16.35 · 2021: $462 · 2022: $96.72 · 2023: $186 · 2024: $150 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $308.72 | 2023-2025 | Austedo, Austedo Xr, Austedo Xr |
| Zimmer Biomet Holdings, INC. | $296.04 | 2019-2020 | |
| Medtronic, INC. | $279.15 | 2022-2025 | Interstim, Cd Horizon Spinal System, Catalyft Pl Expandable Interbody System |
| Checkpoint Surgical, INC | $185.11 | 2021-2022 | |
| Abbvie INC. | $148.65 | 2025 | |
| Spinal Elements, INC. | $138.05 | 2021 | |
| Orthofix Medical, INC. | $110.52 | 2019-2025 | Cervical-Stim, Physio-Stim, Spinal-Stim |
| Boston Scientific Corporation | $70.13 | 2021-2024 | |
| Innovasis INC | $54.57 | 2021 | |
| Ucb, INC. | $53.40 | 2019 | |
| Janssen Biotech, INC. | $40.00 | 2025 | |
| Arbor Pharmaceuticals, INC. | $31.83 | 2019 | |
| Integra Lifesciences Corporation | $29.17 | 2021 | |
| Nuvasive, INC. | $28.91 | 2021 | |
| Spineology INC. | $28.23 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $24.00 | 2024 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $23.76 | 2024 | Synthecel |
| Ethicon US, LLC | $23.09 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.20 | 2022 | |
| Djo, LLC | $17.08 | 2023 | Cmf |
| Cranial Technologies, INC | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Gilmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.